Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma
| Autor: | Yemliha Dolek, Berrin Pehlivan, Oznur Yuksel, Cem Onal, Ali Aydin Yavuz, Erkan Topkan, Melek Nur Yavuz, Gül Nihal Nursal |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
lcsh:Medical physics. Medical radiology. Nuclear medicine
Adult Male Mesothelioma medicine.medical_specialty medicine.medical_treatment lcsh:R895-920 Pleural Neoplasms lcsh:RC254-282 Text mining Fluorodeoxyglucose F18 medicine Humans Radiology Nuclear Medicine and imaging In patient Pleural Neoplasm Radiation treatment planning Aged PET-CT medicine.diagnostic_test business.industry Radiotherapy Planning Computer-Assisted Research Middle Aged medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Radiation therapy Oncology Positron emission tomography Radiology Nuclear Medicine and imaging Positron-Emission Tomography Female Radiology Radiopharmaceuticals business Tomography X-Ray Computed |
| Zdroj: | Radiation Oncology (London, England) Radiation Oncology, Vol 4, Iss 1, p 35 (2009) |
| ISSN: | 1748-717X |
| Popis: | Background When combined with adequate tumoricidal doses, accurate target volume delineation remains to be the one of the most important predictive factors for radiotherapy (RT) success in locally advanced or medically inoperable malignant pleural mesothelioma (MPM) patients. Recently, 18-fluorodeoxyglucose positron emission tomography (PET) has demonstrated significant improvements in diagnosis and accurate staging of MPM. However, role of additional PET data has not been studied in RT planning (RTP) of patients with inoperable MPM or in those who refuse surgery. Therefore, we planned to compare CT with co-registered PET-CT as the basis for delineating target volumes in these patients group. Methods Retrospectively, the CT and co-registered PET-CT data of 13 patients with histologically proven MPM were utilized to delineate target volumes separately. For each patient, target volumes (gross tumor volume [GTV], clinical target volume [CTV], and planning target volume [PTV]) were defined using the CT and PET-CT fusion data sets. The PTV was measured in two ways: PTV1 was CTV plus a 1-cm margin, and PTV2 was GTV plus a 1-cm margin. We analyzed differences in target volumes. Results In 12 of 13 patients, compared to CT-based delineation, PET-CT-based delineation resulted in a statistically significant decrease in the mean GTV, CTV, PTV1, and PTV2. In these 12 patients, mean GTV decreased by 47.1% ± 28.4%, mean CTV decreased by 38.7% ± 24.7%, mean PTV1 decreased by 31.1% ± 23.1%, and mean PTV2 decreased by 40.0% ± 24.0%. In 4 of 13 patients, hilar lymph nodes were identified by PET-CT that was not identified by CT alone, changing the nodal status of tumor staging in those patients. Conclusion This study demonstrated the usefulness of PET-CT-based target volume delineation in patients with MPM. Co-registration of PET and CT information reduces the likelihood of geographic misses, and additionally, significant reductions observed in target volumes may potentially allow escalation of RT dose beyond conventional limits potential clinical benefits in tumor control rates, which needs to be tested in future studies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink